Abstract
Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection is an infrequent and poorly understood illness. It can present as severe multiorgan failure in children, potentially lethal. Immunomodulation is the empiric treatment because a dysregulated immune response is the primary pathophysiologic mechanism. We present an infant with severe MIS-C, refractory to usual treatment, successfully treated with plasmapheresis.
Original language | English |
---|---|
Pages (from-to) | e259-e262 |
Journal | The Pediatric infectious disease journal |
Volume | 40 |
Issue number | 7 |
DOIs | |
Publication status | Published - 1 Jul 2021 |
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)
- Infectious Diseases